Akin S, Gucuk-Ipek E, Hayta U, et al. Long-term dexamethasone treatment increases cardiac galectin-3 levels. Cardiovasc Drugs Ther. 2022. https://doi.org/10.1007/s10557-022-07344-w.

Ospina-Quintero L, Jaramillo JC, Tabares-Guevara JH, Ramírez-Pineda JR. Reformulating small molecules for cardiovascular disease immune intervention: low-dose combined vitamin D/dexamethasone promotes IL-10 production and atheroprotection in dyslipidemic mice. Front Immunol. 2020;11:743.

CAS  Article  Google Scholar 

Wang H, Yao X, Huang K, et al. Low-dose dexamethasone in combination with luteolin improves myocardial infarction recovery by activating the antioxidative response. Biomed Pharmacother. 2022;151:113121.

CAS  Article  Google Scholar 

Tao Z, Loo S, Su L, et al. Dexamethasone inhibits regeneration and causes ventricular aneurysm in the neonatal porcine heart after myocardial infarction. J Mol Cell Cardiol. 2020;144:15–23.

CAS  Article  Google Scholar 

de Salvi GF, de Moraes WM, Bozi LH, et al. Dexamethasone-induced cardiac deterioration is associated with both calcium handling abnormalities and calcineurin signaling pathway activation. Mol Cell Biochem. 2017;424(1-2):87–98.

Article  Google Scholar